ClariVest Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-4
| Closed | -$1K | – | 874 |
|
|
2023
Q3 | $1K | Hold |
4
| – | – | ﹤0.01% | 557 |
|
|
2023
Q2 | $1K | Hold |
4
| – | – | ﹤0.01% | 572 |
|
|
2023
Q1 | $1K | Hold |
4
| – | – | ﹤0.01% | 605 |
|
|
2022
Q4 | $1K | Hold |
4
| – | – | ﹤0.01% | 583 |
|
|
2022
Q3 | $1K | Hold |
4
| – | – | ﹤0.01% | 566 |
|
|
2022
Q2 | $1K | Hold |
4
| – | – | ﹤0.01% | 577 |
|
|
2022
Q1 | $1K | Hold |
4
| – | – | ﹤0.01% | 613 |
|
|
2021
Q4 | $1K | Hold |
4
| – | – | ﹤0.01% | 662 |
|
|
2021
Q3 | $1K | Hold |
4
| – | – | ﹤0.01% | 659 |
|
|
2021
Q2 | $1K | Hold |
4
| – | – | ﹤0.01% | 651 |
|
|
2021
Q1 | $1K | Hold |
4
| – | – | ﹤0.01% | 629 |
|
|
2020
Q4 | $1K | Hold |
4
| – | – | ﹤0.01% | 649 |
|
|
2020
Q3 | $1K | Hold |
4
| – | – | ﹤0.01% | 641 |
|
|
2020
Q2 | $1K | Sell |
4
-16,696
| -100% | -$4.17M | ﹤0.01% | 708 |
|
|
2020
Q1 | $1.82M | Buy |
16,700
+1,300
| +8% | +$142K | 0.05% | 208 |
|
|
2019
Q4 | $1.77M | Sell |
15,400
-500
| -3% | -$57.6K | 0.04% | 263 |
|
|
2019
Q3 | $1.28M | Sell |
15,900
-200
| -1% | -$16.1K | 0.03% | 317 |
|
|
2019
Q2 | $1.17M | Sell |
16,100
-100
| -0.6% | -$7.26K | 0.03% | 296 |
|
|
2019
Q1 | $1.51M | Sell |
16,200
-400
| -2% | -$37.4K | 0.03% | 352 |
|
|
2018
Q4 | $1.21M | Hold |
16,600
| – | – | 0.03% | 370 |
|
|
2018
Q3 | $1.45M | Hold |
16,600
| – | – | 0.03% | 371 |
|
|
2018
Q2 | $1.64M | Sell |
16,600
-2,900
| -15% | -$286K | 0.03% | 371 |
|
|
2018
Q1 | $2.32M | Hold |
19,500
| – | – | 0.04% | 319 |
|
|
2017
Q4 | $2.48M | Buy |
+19,500
| New | +$2.48M | 0.04% | 313 |
|
|
2015
Q2 | – | Sell |
-6,734
| Closed | -$703K | – | 603 |
|
|
2015
Q1 | $703K | Sell |
6,734
-94
| -1% | -$9.81K | 0.02% | 318 |
|
|
2014
Q4 | $662K | Sell |
6,828
-13
| -0.2% | -$1.26K | 0.02% | 261 |
|
|
2014
Q3 | $535K | Sell |
6,841
-6
| -0.1% | -$469 | 0.02% | 267 |
|
|
2014
Q2 | $432K | Buy |
6,847
+9
| +0.1% | +$568 | 0.02% | 286 |
|
|
2014
Q1 | $459K | Buy |
+6,838
| New | +$459K | 0.02% | 273 |
|